CF Acquisition Corp. VII Announces Postponement of its Special Meeting of Stockholders and Extension of Redemption Date
- The postponement of the special meeting may indicate that there is ongoing discussion or negotiation regarding the business combination, which could potentially lead to a more favorable outcome for stockholders.
- The extension of the deadline for stockholders to submit their shares for redemption provides more flexibility for those who may want to reconsider their decision.
- The agreement by the Sponsor to loan $0.03 per month for each public share not redeemed until March 20, 2024, provides additional financial support for the Company to complete a business combination.
- The uncertainty surrounding the extension of the completion date for a business combination may create volatility in the stock price.
- Stockholders who have already submitted their proxy or voted may be concerned about potential changes in the outcome of the meeting.
- The possibility of stockholders withdrawing their redemption requests could impact the amount of funds available for the Company's business combination.
The Meeting is for stockholders to consider amending the Company's amended and restated certificate of incorporation ("Extension Amendment") to extend the date by which the Company must completing a business combination from June 20, 2023 to March 20, 2024 or such earlier date as determined by the board of directors of the Company (the "Extension").
The record date for the Meeting to vote on the Extension remains the close of business on May 1, 2023 (the "Record Date"). Stockholders who have previously submitted their proxy or otherwise voted and who do not want to change their vote need not take any action. Stockholders as of the Record Date can vote, even if they have subsequently sold their shares.
Stockholders can continue to vote by internet or by calling the Company's proxy solicitor, Morrow Sodali, LLC ("Morrow Sodali"), at (800) 662-5200 (toll free). Votes will be accepted up to and during the postponed meeting. If stockholders have any questions or need assistance, please contact Morrow Sodali at (800) 662-5200 (toll free) or by email at CFFS.info@investor.morrowsodali.com.
In connection with the postponed Meeting date, the Company has extended the deadline for holders of the Company's Class A common stock issued in the Company's initial public offering to submit their shares for redemption in connection with the Extension to 5:00 p.m. Eastern Time on June 14, 2023. Stockholders who wish to withdraw their previously submitted redemption request may do so prior to the rescheduled meeting by requesting that the transfer agent return such shares.
If the Extension Amendment is approved and implemented, the Sponsor has agreed to loan to the Company, which will be deposited into the Company's trust account,
About CF Acquisition Corp. VII
CF Acquisition Corp. VII is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company's efforts to identify a prospective target business is not limited to a particular industry or geographic region, but the Company intends to focus on industries where its management team and founders have experience, including the financial services, healthcare, real estate services, technology and software industries. CF Acquisition Corp. VII is led by Chairman and Chief Executive Officer Howard W. Lutnick.
Participants in the Solicitation
The Company and its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies from the Company's stockholders in respect of the Extension. Information regarding the Company's directors and executive officers is available in its annual report on Form 10-K filed with the SEC. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests are contained in the proxy statement filed by the Company on May 19, 2023 (the "Proxy Statement").
No Offer or Solicitation
This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Additional Information
The Company has filed the Proxy Statement with the Securities and Exchange Commission (the "SEC") in connection with the Meeting and, beginning on May 22, 2023, mailed the Proxy Statement and other relevant documents to its stockholders as of the May 1, 2023 record date for the Meeting. The Company's stockholders and other interested persons are advised to read the Proxy Statement and any other relevant documents that have been or will be filed with the SEC in connection with the Company's solicitation of proxies for the Meeting because these documents will contain important information about the Company, the Extension and related matters. Stockholders may also obtain a free copy of the Proxy Statement, as well as other relevant documents that have been or will be filed with the SEC, without charge, at the SEC's website located at www.sec.gov or by directing a request to Morrow Sodali, LLC at (800) 662-5200 (toll free) or by email at CFFS.info@investor.morrowsodali.com.
Forward-Looking Statements
This press release and oral statements made from time to time by representatives of the Company may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to the Company or its management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the Company's initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cf-acquisition-corp-vii-announces-postponement-of-its-special-meeting-of-stockholders-and-extension-of-redemption-date-301848629.html
SOURCE CF Acquisition Corp. VII
FAQ
What is CF Acquisition Corp. VII?
Why was the special meeting of stockholders postponed?
What is the record date for the meeting?
Can stockholders still vote and submit their shares for redemption?
What happens if the extension is approved?
